Insufficient scRNA-seq data for expression of TAS2R5 at single-cell level.
Insufficient scRNA-seq data for expression of TAS2R5 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 85% | 69.59 | 2234 / 2642 | 85% | 2.66 | 602 / 705 |
ovary | 100% | 207.27 | 180 / 180 | 62% | 1.81 | 268 / 430 |
pancreas | 96% | 57.27 | 316 / 328 | 65% | 1.36 | 115 / 178 |
kidney | 98% | 71.38 | 87 / 89 | 61% | 1.89 | 551 / 901 |
breast | 99% | 109.13 | 453 / 459 | 59% | 1.38 | 665 / 1118 |
esophagus | 97% | 70.95 | 1403 / 1445 | 60% | 1.48 | 109 / 183 |
lung | 99% | 85.47 | 572 / 578 | 57% | 1.33 | 660 / 1155 |
intestine | 99% | 88.81 | 953 / 966 | 56% | 1.20 | 295 / 527 |
thymus | 100% | 113.59 | 651 / 653 | 55% | 1.15 | 332 / 605 |
bladder | 100% | 90.57 | 21 / 21 | 49% | 1.21 | 249 / 504 |
prostate | 100% | 120.73 | 245 / 245 | 48% | 0.89 | 239 / 502 |
stomach | 92% | 57.01 | 332 / 359 | 50% | 1.15 | 144 / 286 |
uterus | 100% | 171.58 | 170 / 170 | 39% | 0.79 | 177 / 459 |
skin | 98% | 123.37 | 1765 / 1809 | 34% | 0.75 | 160 / 472 |
adrenal gland | 83% | 39.13 | 214 / 258 | 25% | 0.41 | 58 / 230 |
spleen | 100% | 106.16 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 97% | 83.21 | 1173 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 93% | 61.37 | 1240 / 1335 | 0% | 0 | 0 / 0 |
liver | 71% | 26.36 | 160 / 226 | 14% | 0.33 | 57 / 406 |
heart | 74% | 36.36 | 637 / 861 | 0% | 0 | 0 / 0 |
muscle | 71% | 28.05 | 574 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 27% | 17.17 | 254 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 27% | 0.45 | 12 / 45 |
eye | 0% | 0 | 0 / 0 | 25% | 0.44 | 20 / 80 |
lymph node | 0% | 0 | 0 / 0 | 24% | 0.40 | 7 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0001580 | Biological process | detection of chemical stimulus involved in sensory perception of bitter taste |
GO_0007635 | Biological process | chemosensory behavior |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0004930 | Molecular function | G protein-coupled receptor activity |
GO_0005515 | Molecular function | protein binding |
GO_0008527 | Molecular function | taste receptor activity |
GO_0033038 | Molecular function | bitter taste receptor activity |
Gene name | TAS2R5 |
Protein name | Taste receptor type 2 member 5 (T2R5) Taste receptor type 2 |
Synonyms | hCG_1641702 tcag7.329 |
Description | FUNCTION: Receptor that may play a role in the perception of bitterness and is gustducin-linked. May play a role in sensing the chemical composition of the gastrointestinal content. The activity of this receptor may stimulate alpha gustducin, mediate PLC-beta-2 activation and lead to the gating of TRPM5. FUNCTION: Receptor that may play a role in the perception of bitterness and is gustducin-linked. May play a role in sensing the chemical composition of the gastrointestinal content. The activity of this receptor may stimulate alpha gustducin, mediate PLC-beta-2 activation and lead to the gating of TRPM5. . FUNCTION: Receptor that may play a role in the perception of bitterness and is gustducin-linked. May play a role in sensing the chemical composition of the gastrointestinal content. The activity of this receptor may stimulate alpha gustducin, mediate PLC-beta-2 activation and lead to the gating of TRPM5. . |
Accessions | Q9NYW4 Q502V5 ENST00000247883.5 A4D1U0 |